Cognetivity is a bio-pharmaceuticals firm that develops therapy and neuromodulation platform for the treatment of dementia
Business Model:
Revenue: $0
Employees: 1-10
Address: 3 Waterhouse Square
City: London
State: england
Zip: EC1N 2SW
Country: GB
Cognetivity is a bio-pharmaceuticals firm that develops therapy and neuromodulation platform for the treatment of dementia
Contact Phone:
Contact Email:
Listed Exchange:
CSE
IPO Date:
3/20/2018
Ticker Symbol:
CGN
Opened: -/share
EBITDA | - |
Total Cash | - |
Total Debt | - |
Total Revenue | - |
Total Profit (Gross) | - |
PE Ratio | - |
Announced Date | Company | Transaction | Money Raised |
---|
Announced Date | Transaction | Number of Investors | Money Raised | Lead Investors | 2/2022 | Private Placement | $867k | 3/2021 | Debt | $1M | 12/2021 | Post-IPO Equity | $856.7k | 10/2022 | Private Placement | $4.5M | 1/2022 | Private Placement | $1.3M | 12/2020 | Private Placement | $2.7M | 9/2018 | Post-IPO Equity | - |
Rockshield Capital Rockshield Capital |
10/2019 | Grant | 1 | $994.2k |
Innovate UK Innovate UK |
9/2018 | Post-IPO Equity | 1 | - |
Rockshield Capital Rockshield Capital |
---|
Announced Date | Name | Price |
---|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|